Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Colorectal Neoplasms × magrolimab × Clear all

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 4 Squamous Cell Carcinoma of Head and Neck 2 Triple Negative Breast Neoplasms 1 Solid Tumor 1 Sezary Syndrome 1 Myeloid Malignancies 1 Mycosis Fungoides 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Colorectal Neoplasms 1

Interventions

Irinotecan 49 Bevacizumab 47 Oxaliplatin 43 Leucovorin 42 Fluorouracil 42 Capecitabine 40 Cetuximab 38 pembrolizumab 18 IFL protocol 12 regorafenib 8 Nivolumab 8 Panitumumab 7 Cyclophosphamide 6 Colonoscopy 6 trifluridine tipiracil drug combination 5 atezolizumab 5 Radiotherapy 5 Metformin 5 Immunohistochemistry 5 Celecoxib 5 spartalizumab 4 Trastuzumab 4 Surgical Procedures, Operative 4 Mitomycin 4 Interleukin-2 4 Gene Expression Profiling 4 Gemcitabine 4 Folfox protocol 4 Docetaxel 4 Chemotherapy, Adjuvant 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05330429 2025-07-01

ELEVATE CRC

Gilead Sciences

Phase 2 Terminated

77 enrolled 22 charts

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡